AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33
GENE-THERAPY FOR DRUG-INDUCED MYELOTOXICITY - INDUCTION OF CYCLOPHOSPHAMIDE RESISTANCE BY ALDEHYDE DEHYDROGENASE-1 GENE-TRANSFER
Authors: MAGNI M SHAMMAH S SCHIRO R BREGNI M SIENA S DINICOLA M DALLAFAVERA R GIANNI AM
Citation: M. Magni et al., GENE-THERAPY FOR DRUG-INDUCED MYELOTOXICITY - INDUCTION OF CYCLOPHOSPHAMIDE RESISTANCE BY ALDEHYDE DEHYDROGENASE-1 GENE-TRANSFER, Blood, 84(10), 1994, pp. 10000357-10000357
CLINICAL IMPLICATIONS OF THE HETEROGENEITY OF HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY ANTICANCER THERAPY WITH CYCLOPHAMIDE AND CYTOKINE(S)
Authors: SIENA S BREGNI M BONSI L STRIPPOLI P PECCATORI F MAGNI M DINICOLA M BAGNARA GP GIANNI AM
Citation: S. Siena et al., CLINICAL IMPLICATIONS OF THE HETEROGENEITY OF HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY ANTICANCER THERAPY WITH CYCLOPHAMIDE AND CYTOKINE(S), Stem cells, 11, 1993, pp. 72-75
RECOMBINANT HUMAN INTERLEUKIN-3 HASTENS TRILINEAGE HEMATOPOIETIC RECOVERY FOLLOWING HIGH-DOSE (7 G M(2)) CYCLOPHOSPHAMIDE CANCER-THERAPY/
Authors: GIANNI AM SIENA S BREGNI M DINICOLA M PECCATORI F MAGNI M RAVAGNANI F SKLENAR I BONADONNA G
Citation: Am. Gianni et al., RECOMBINANT HUMAN INTERLEUKIN-3 HASTENS TRILINEAGE HEMATOPOIETIC RECOVERY FOLLOWING HIGH-DOSE (7 G M(2)) CYCLOPHOSPHAMIDE CANCER-THERAPY/, Annals of oncology, 4(9), 1993, pp. 759-766
HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - A 6-YEARUPDATE
Authors: GIANNI AM SIENA S BREGNI M LOMBARDI F GANDOLA L DINICOLA M MAGNI M PECCATORI F VALAGUSSA P BONADONNA G
Citation: Am. Gianni et al., HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - A 6-YEARUPDATE, Annals of oncology, 4(10), 1993, pp. 889-891
GENE-TRANSFER INTO PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS FROM CANCER-PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND GROWTH FACTOR(S)
Authors: BREGNI M MAGNI M SIENA S DINICOLA M PECCATORI F RAVAGNANI F BONADONNA G GIANNI AM
Citation: M. Bregni et al., GENE-TRANSFER INTO PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS FROM CANCER-PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND GROWTH FACTOR(S), Journal of cellular biochemistry, 1993, pp. 229-229
CLINICAL-APPLICATION OF GROWTH-FACTORS FOR COLLECTION OF CIRCULATING HEMATOPOIETIC PROGENITORS IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CYCLOPHOSPHAMIDE
Authors: RAVAGNANI F NOTTI P SIENA S BREGNI M ZORZINO L DINICOLA M BELLI N GIANNI AM PELLEGRIS G
Citation: F. Ravagnani et al., CLINICAL-APPLICATION OF GROWTH-FACTORS FOR COLLECTION OF CIRCULATING HEMATOPOIETIC PROGENITORS IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CYCLOPHOSPHAMIDE, International journal of artificial organs, 16, 1993, pp. 35-38
QUANTIZATION OF CD34-BLOOD HEMATOPOIETIC PROGENITORS FOR AUTOGRAFTINGIN CANCER-PATIENTS( PERIPHERAL)
Authors: DINICOLA M SIENA S BREGNI M PECCATORI F MAGNI M RAVAGNANI F ZORZINO L BONADONNA G GIANNI AM
Citation: M. Dinicola et al., QUANTIZATION OF CD34-BLOOD HEMATOPOIETIC PROGENITORS FOR AUTOGRAFTINGIN CANCER-PATIENTS( PERIPHERAL), International journal of artificial organs, 16, 1993, pp. 80-82
RHGM-CSF OR RHG-CSF TO ENHANCE CIRCULATION OF HEMATOPOIETIC PROGENITORS AND TO AMELIORATE THE HEMATOLOGIC TOXICITY OF HIGH-DOSE CYCLOPHOSPHAMIDE (HD-CTX) CANCER-THERAPY
Authors: BREGNI M SIENA S DINICOLA M MAGNI M PECCATORI F RAVAGNANI F BONADONNA G GIANNI AM
Citation: M. Bregni et al., RHGM-CSF OR RHG-CSF TO ENHANCE CIRCULATION OF HEMATOPOIETIC PROGENITORS AND TO AMELIORATE THE HEMATOLOGIC TOXICITY OF HIGH-DOSE CYCLOPHOSPHAMIDE (HD-CTX) CANCER-THERAPY, Blood, 82(10), 1993, pp. 10000495-10000495
Risultati: 1-25 | 26-33 |